Pediatric Preventive Screening
Defines laboratory reimbursement criteria for preventive screening tests for individuals newborn through age 18 (excluding newborn genetic disorder screening), including which screenings may be reimbursable and associated age- or risk-based conditions. Includes procedure code list and plan/version metadata applicable to BCBSNM products.
Document updated with literature review and reimbursement information revised for clarity on 7/17/2023.
Initial policy created 11/1/2022.
Policy summary
BCBSNM policy CPCPLAB016 establishes laboratory reimbursement criteria for pediatric preventive screening tests for individuals from newborn through age 18 years. The policy is intended to guide reimbursement for age- and risk-based pediatric screening (e.g., newborn panels, lead, anemia, tuberculosis, dyslipidemia, sickle cell, hypothyroidism, hyperbilirubinemia) and references guideline organizations including the AAP, CDC, USPSTF, and HRSA. Coverage stance for the policy is mixed.